EE200100096A - Asatsüklilise tüvistruktuuriga tsükliline ühend, seda sisaldav farmatseutiline kompositsioon ning selle kasutamine ravimina - Google Patents
Asatsüklilise tüvistruktuuriga tsükliline ühend, seda sisaldav farmatseutiline kompositsioon ning selle kasutamine raviminaInfo
- Publication number
- EE200100096A EE200100096A EEP200100096A EEP200100096A EE200100096A EE 200100096 A EE200100096 A EE 200100096A EE P200100096 A EEP200100096 A EE P200100096A EE P200100096 A EEP200100096 A EE P200100096A EE 200100096 A EE200100096 A EE 200100096A
- Authority
- EE
- Estonia
- Prior art keywords
- azacyclic
- medicament
- pharmaceutical composition
- composition containing
- cyclic compound
- Prior art date
Links
- 150000001923 cyclic compounds Chemical class 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9697798P | 1998-08-18 | 1998-08-18 | |
| PCT/US1999/018570 WO2000011001A1 (en) | 1998-08-18 | 1999-08-16 | Muscarinic agonists and antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE200100096A true EE200100096A (et) | 2002-06-17 |
Family
ID=22260061
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP200100096A EE200100096A (et) | 1998-08-18 | 1999-08-16 | Asatsüklilise tüvistruktuuriga tsükliline ühend, seda sisaldav farmatseutiline kompositsioon ning selle kasutamine ravimina |
Country Status (30)
| Country | Link |
|---|---|
| US (5) | US6093724A (et) |
| EP (1) | EP1112272B1 (et) |
| JP (1) | JP2002523416A (et) |
| KR (1) | KR20010072784A (et) |
| CN (1) | CN1312812A (et) |
| AR (1) | AR020199A1 (et) |
| AT (1) | ATE227724T1 (et) |
| AU (1) | AU750566B2 (et) |
| BG (1) | BG105256A (et) |
| BR (1) | BR9913072A (et) |
| CA (1) | CA2340946A1 (et) |
| CO (1) | CO5130018A1 (et) |
| DE (1) | DE69903961T2 (et) |
| EE (1) | EE200100096A (et) |
| ES (1) | ES2191455T3 (et) |
| HK (1) | HK1038918A1 (et) |
| HU (1) | HUP0103203A3 (et) |
| ID (1) | ID27544A (et) |
| IL (1) | IL141050A0 (et) |
| IS (1) | IS5827A (et) |
| NO (1) | NO20010804L (et) |
| NZ (1) | NZ509762A (et) |
| PE (1) | PE20000988A1 (et) |
| PL (1) | PL346247A1 (et) |
| RU (1) | RU2219179C2 (et) |
| SK (1) | SK1892001A3 (et) |
| TR (1) | TR200100462T2 (et) |
| WO (1) | WO2000011001A1 (et) |
| YU (1) | YU13301A (et) |
| ZA (1) | ZA200100978B (et) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP0301442A3 (en) * | 2000-10-19 | 2007-03-28 | Pfizer Prod Inc | Bridged piperazine derivatives and pharmaceutical compositions containing them |
| GB0117950D0 (en) * | 2001-02-16 | 2001-09-19 | Aventis Pharma Inc | Novel heterocyclic urea derivatives andd their use as dopamine D3 receptor ligands |
| WO2002094827A1 (en) * | 2001-05-23 | 2002-11-28 | Neurosearch A/S | Fused tropane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| US20030064979A1 (en) * | 2001-06-29 | 2003-04-03 | Hansen Thomas Kruse | Method of inhibiting PTP 1B and /or T-cell PTP and/or other PTPases with an Asp residue at position 48 |
| US6828328B1 (en) * | 2002-03-01 | 2004-12-07 | Ucb S.A. | Analgesic combination of muscarinic agonists |
| US7897766B2 (en) * | 2005-09-23 | 2011-03-01 | Abbott Laboratories | Amino-aza-adamantane derivatives and methods of use |
| US8314119B2 (en) * | 2006-11-06 | 2012-11-20 | Abbvie Inc. | Azaadamantane derivatives and methods of use |
| US8076350B2 (en) * | 2006-12-22 | 2011-12-13 | Abbott Laboratories | Spirocyclic azaadamantane derivatives and methods of use |
| MX2009010176A (es) * | 2007-03-23 | 2009-10-12 | Abbott Lab | Derivados de aza-adamantano 4-substituidos y metodos de uso de los mismos. |
| MX2009010175A (es) | 2007-03-23 | 2009-10-12 | Abbott Lab | Derivados de acetamida y carboxamida de aza-adamantano y metodos de uso de los mismos. |
| KR20120044978A (ko) * | 2009-06-19 | 2012-05-08 | 아보트 러보러터리즈 | 디아자호모아다만탄 유도체 및 이들의 사용 방법 |
| US10265311B2 (en) | 2009-07-22 | 2019-04-23 | PureTech Health LLC | Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation |
| EP3061821B1 (en) | 2009-07-22 | 2019-07-10 | Puretech Health LLC | Compositions for treatment of disorders ameliorated by muscarinic receptor activation |
| AR081626A1 (es) | 2010-04-23 | 2012-10-10 | Cytokinetics Inc | Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos |
| EP2560488B1 (en) | 2010-04-23 | 2015-10-28 | Cytokinetics, Inc. | Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use |
| AR081331A1 (es) | 2010-04-23 | 2012-08-08 | Cytokinetics Inc | Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos |
| US9464078B2 (en) | 2010-09-23 | 2016-10-11 | Abbvie Inc. | Monohydrate of azaadamantane derivatives |
| US8759380B2 (en) | 2011-04-22 | 2014-06-24 | Cytokinetics, Inc. | Certain heterocycles, compositions thereof, and methods for their use |
| AU2018300980A1 (en) | 2017-07-12 | 2020-01-02 | Vanderbilt University | Antagonists of the muscarinic acetylcholine receptor M4 |
| ES3064093T3 (en) | 2017-10-20 | 2026-04-22 | Univ Vanderbilt | Antagonists of the muscarinic acetylcholine receptor m4 |
| WO2019126559A1 (en) | 2017-12-20 | 2019-06-27 | Vanderbilt University | Antagonists of the muscarinic acetylcholine receptor m4 |
| IL281809B (en) | 2018-09-28 | 2022-09-01 | Karuna Therapeutics Inc | Compositions and methods for the treatment of diseases improved by the activation of muscarinic receptors |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4739074A (en) * | 1986-01-22 | 1988-04-19 | Pennwalt Corporation | Adamantane spiro-pyrrolidine derivatives |
| IE63906B1 (en) * | 1987-11-13 | 1995-06-14 | Novo Nordisk As | Azabicyclic compounds and their preparation and use |
| US5527813A (en) * | 1990-08-21 | 1996-06-18 | Novo Nordisk A/S | Heterocyclic compounds and their preparation and use |
| WO1992011261A1 (en) * | 1990-12-21 | 1992-07-09 | Merck Sharp & Dohme Limited | 4-azatricyclo[2.2.1.02,6]heptanes and pharmaceutical compositions |
| US5955470A (en) * | 1991-06-11 | 1999-09-21 | Merrell Pharmaceuticals, Inc. | Derivatives of amide analogs of certain methano bridged quinolizines |
| US5641791A (en) * | 1991-08-13 | 1997-06-24 | Novo Nordisk A.S | Heterocyclic compounds and their preparation and use |
| AU702720B2 (en) * | 1995-11-02 | 1999-03-04 | Neurosearch A/S | Fused tropane-derivatives as neurotransmitter reuptake inhibitors |
| US5914338A (en) * | 1996-04-02 | 1999-06-22 | Novo Nordisk | Heterocyclic compounds and their preparation and use |
| US5952339A (en) * | 1998-04-02 | 1999-09-14 | Bencherif; Merouane | Pharmaceutical compositions and methods of using nicotinic antagonists for treating a condition or disorder characterized by alteration in normal neurotransmitter release |
| US5986100A (en) * | 1998-04-02 | 1999-11-16 | Crooks; Peter Anthony | Pharmaceutical compositions and methods for use |
| US6057446A (en) * | 1998-04-02 | 2000-05-02 | Crooks; Peter Anthony | Certain 1-aza-tricyclo [3.3.1-13,7 ] decane compounds |
-
1999
- 1999-08-16 ID IDW20010377A patent/ID27544A/id unknown
- 1999-08-16 PL PL99346247A patent/PL346247A1/xx not_active Application Discontinuation
- 1999-08-16 ES ES99945064T patent/ES2191455T3/es not_active Expired - Lifetime
- 1999-08-16 TR TR2001/00462T patent/TR200100462T2/xx unknown
- 1999-08-16 CA CA002340946A patent/CA2340946A1/en not_active Abandoned
- 1999-08-16 IL IL14105099A patent/IL141050A0/xx unknown
- 1999-08-16 US US09/375,149 patent/US6093724A/en not_active Expired - Fee Related
- 1999-08-16 AU AU57758/99A patent/AU750566B2/en not_active Ceased
- 1999-08-16 AT AT99945064T patent/ATE227724T1/de not_active IP Right Cessation
- 1999-08-16 HK HK02100409.3A patent/HK1038918A1/zh unknown
- 1999-08-16 BR BR9913072-6A patent/BR9913072A/pt not_active IP Right Cessation
- 1999-08-16 NZ NZ509762A patent/NZ509762A/xx unknown
- 1999-08-16 CN CN99809775A patent/CN1312812A/zh active Pending
- 1999-08-16 YU YU13301A patent/YU13301A/sh unknown
- 1999-08-16 KR KR1020017002128A patent/KR20010072784A/ko not_active Withdrawn
- 1999-08-16 EE EEP200100096A patent/EE200100096A/et unknown
- 1999-08-16 JP JP2000566274A patent/JP2002523416A/ja active Pending
- 1999-08-16 SK SK189-2001A patent/SK1892001A3/sk unknown
- 1999-08-16 HU HU0103203A patent/HUP0103203A3/hu unknown
- 1999-08-16 WO PCT/US1999/018570 patent/WO2000011001A1/en not_active Ceased
- 1999-08-16 RU RU2001107139/04A patent/RU2219179C2/ru not_active IP Right Cessation
- 1999-08-16 DE DE69903961T patent/DE69903961T2/de not_active Expired - Fee Related
- 1999-08-16 EP EP99945064A patent/EP1112272B1/en not_active Expired - Lifetime
- 1999-08-17 AR ARP990104100A patent/AR020199A1/es unknown
- 1999-08-18 PE PE1999000838A patent/PE20000988A1/es not_active Application Discontinuation
- 1999-08-18 CO CO99052330A patent/CO5130018A1/es unknown
-
2000
- 2000-05-09 US US09/567,785 patent/US6251916B1/en not_active Expired - Fee Related
- 2000-10-17 US US09/690,494 patent/US6323194B1/en not_active Expired - Fee Related
-
2001
- 2001-01-26 IS IS5827A patent/IS5827A/is unknown
- 2001-02-05 ZA ZA200100978A patent/ZA200100978B/xx unknown
- 2001-02-14 BG BG105256A patent/BG105256A/xx unknown
- 2001-02-16 NO NO20010804A patent/NO20010804L/no not_active Application Discontinuation
- 2001-10-05 US US09/972,415 patent/US6423842B1/en not_active Expired - Fee Related
-
2002
- 2002-03-27 US US10/108,046 patent/US6555550B1/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL144910A0 (en) | Cyclic compounds and pharmaceutical compositions containing the same | |
| IL142531A0 (en) | Cyclic peptide compound, processes for the preparation thereof and pharmaceutical compositions containing the same | |
| HUP0204071A3 (en) | Nitrogenous cyclic compounds and pharmaceutical compositions containing the same and their use | |
| BR0014526B1 (pt) | compostos cíclicos de seis elementos contendo nitrogênio aromático, composição farmacêutica e uso do mesmo | |
| HUP0300203A3 (en) | Novel cyclic amide derivatives, and pharmaceutical compositions containing same | |
| HUP0103265A3 (en) | Cyclic prosaposin-derived peptides, pharmaceutical compositions comprising thereof and their use | |
| FI991485A0 (fi) | Uusi farmaseuttinen koostumus | |
| HUP0004310A3 (en) | Cyclic amino acids, and derivatives thereof and pharmaceutical compositions comprising the said compounds as active agents | |
| IL159086A0 (en) | 3-aryl-5-aryl- [1, 2, 4] -oxadiazole derivatives and pharmaceutical compositions containing the same | |
| DK1052974T3 (da) | Farmaceutisk sammensætning indeholdende epothilon | |
| IL158168A0 (en) | 5-membered, nitrogen-containing heterocyclic compounds and pharmaceutical compositions containing the same | |
| HUP0100950A3 (en) | Cyclic amino compounds, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing them | |
| HUP0102676A3 (en) | Solid, quick dissolving pharmaceutical compositions containing cetrizine | |
| EE200000482A (et) | Glütsiini ülekannet pärssiva ühendi kasutamine ravimi valmistamiseks, ühend, seda sisaldav kompositsioon ning meetod ühendi ja kompositsiooni valmistamiseks | |
| EE200000483A (et) | Glütsiini ülekannet pärssiva ühendi kasutamine ravimi valmistamiseks, ühend, seda sisaldav kompositsioon ning meetod ühendi ja kompositsiooni valmistamiseks | |
| AU2001228811A1 (en) | Nitrogen-containing 5-membered cyclic compounds and drugs containing these compounds as the active ingredient | |
| EE200300488A (et) | Lipiiditaset alandava toimega bifenüülkarboksamiidühend, meetod selle valmistamiseks ning seda sisaldav ravimkompositsioon | |
| HUP0401733A3 (en) | Cyclic amine-derivatives and pharmaceutical compositions containing them | |
| DE10084344T1 (de) | Cyclosporin enthaltende pharmazeutische Zusammensetzung | |
| EE200200109A (et) | Asendatud 3-fenüül-5-alkoksü-1,3,4-oksdiasool-2-oon, selle valmistamine ja kasutamine lipaasi inhibiitorina ning seda sisaldav ravim | |
| EE200300398A (et) | Isoksasoliini derivaat, selle saamine ja kasutamine depresioonivastase ravimi valmistamiseks ning seda sisaldav ravimkompositsioon | |
| PT1227817E (pt) | Composicao farmaceutica aquosa contendo ciclesonida | |
| EE05406B1 (et) | Memnopeptiidhend, selle valmistamine ja kasutamine ning seda sisaldav farmatseutiline kompositsioon | |
| HUP0201696A3 (en) | Cyclic peptides, pharmaceutical compositions comprising thereof and their use | |
| IL150904A0 (en) | Cyclic hexapeptide derivatives and pharmaceutical compositions containing the same |